FMR LLC

Position in ACRV — Acrivon Therapeutics, Inc.

CIK 315066 BOSTON, MA

Position in ACRV

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$12,383

-$713 QoQ

Shares Held

6,957

-26.2% QoQ

Ownership

0.016%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#32

of 46 holders

Holding Since

Mar 2023

14 quarters on record

Voting authority Sole 99% Shared 0% None 1%

Healthcare · as of Jun 30, 2026

FMR LLC holds $61,424,667,384 across 370 Biotechnology names. ACRV ranks #303 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ARGX	Argenx SE	5,231,452	$4,853,584,218
2	ALNY	Alnylam Pharmaceuticals, Inc.	15,023,962	$4,522,663,276
3	MRNA	Moderna, Inc.	51,859,891	$3,631,748,165
4	ROIV	Roivant Sciences Ltd.	81,020,390	$2,867,311,601
5	RVMD	Revolution Medicines, Inc.	12,200,422	$2,284,895,029
6	IONS	Ionis Pharmaceuticals Inc	24,631,956	$1,953,067,789
7	INSM	INSMED Inc	16,143,583	$1,721,228,815
8	KRYS	Krystal Biotech, Inc.	4,418,197	$1,642,111,277

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$12,383	6,957	-26.2%	Shares	Defined	2026-08-13
2026-03-31	$13,096	9,422	+9.3%	Shares	Defined	2026-05-15
2025-12-31	$20,779	8,622	0.0%	Shares	Defined	2026-02-17
2025-09-30	$15,605	8,622	-12.5%	Shares	Defined	2025-11-13
2025-06-30	$11,721	9,850	+269.6%	Shares	Defined	2025-08-14
2025-03-31	$5,409	2,665	-9.1%	Shares	Defined	2025-05-12
2024-12-31	$17,656	2,933	+13.6%	Shares	Defined	2025-02-13
2024-09-30	$18,067	2,581	+56.6%	Shares	Defined	2024-11-13
2024-06-30	$9,558	1,648	+60.5%	Shares	Defined	2024-08-13
2024-03-31	$7,343	1,027	+27.4%	Shares	Defined	2024-05-13
2023-12-31	$3,965	806	+179.9%	Shares	Defined	2024-02-13
2023-09-30	$2,753	288	-31.8%	Shares	Defined	2023-11-13
2023-06-30	$5,469	422	+245.9%	Shares	Defined	2023-08-11
2023-03-31	$1,548	122	—	Shares	Defined	2023-08-11
No filing history on record for this holder in this stock.